ClinicalTrials.gg
DrugBiological

Evolocumab clinical trials

Also written Repatha and AMG 145.

studies test it
108
open now
14
in phase 3
37
first study started
2010

How each study uses evolocumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the evolocumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Aug 2015 · REPATHA · BLA 125522 (FDA, Drugs@FDA)
European Union
17 Jul 2015 · Repatha · EMEA/H/C/003766 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Evolocumab
83
Evolocumab 140 MG/ML
5
Evolocumab 140 MG/ML [Repatha]
3
EvoMab
2
Evolocumab AI/pen
2

Brand

Repatha
69

Development codes

AMG 145
38

Studies by the year they started

106 studies that test it; most in 2019 (16); 2 more planned to start later

Studies that test evolocumab, by start year
YearStudies
20101
20115
20124
201311
20144
20151
20167
20176
201810
201916
20208
202111
20228
20235
20243
20252
20264

Who runs them

Industry 45 · Other 63

Amgen (42) · Johns Hopkins University (3) · Brigham and Women's Hospital (2) · NYU Langone Health (2) · Policlinico Casilino ASL RMB (2) · Leonardo Clavijo (2) · M.D. Anderson Cancer Center (1) · Assistance Publique - Hôpitaux de Paris (1)

Often tested with

Tested in the same studies.

Alirocumab (3) · Atorvastatin (3) · Ezetimibe (3) · Rosuvastatin (2) · Statins (2) · Nivolumab (1) · Simvastatin (1) · Bempedoic acid (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test evolocumab.

Studies

Open first, then newest update. How each study uses evolocumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 108

See all 108 studies that test evolocumab →

Given beside what is tested · 4 — evolocumab is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with evolocumab

Codes

What other systems call evolocumab · ClinicalTrials.gg INT006205

  • MeSH (NLM) C577155evolocumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) LKC0U3A8NJEVOLOCUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1665684Confirmed FDA, Wikidata
  • Wikidata Q15623825evolocumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C174672EvolocumabOne source FDA
  • DrugBank DB09303One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.